Click on the links below to view the latest news stories from leading media outlets highlighting ODPRN research and scientists.
Patients with overactive bladder who were dispensed mirabegron did not have an increased risk for CV events compared with other treatments, according to a study published in JAMA Internal Medicine.
Meanwhile, a new report from the Ontario Drug Policy Research Network looked at 1,337 opioid-related deaths in the province from July 2017 to June 2018.
Of the 147,303 publicly funded naloxone kits distributed across the province between July 2017 and June 2018, 8,657 were handed out in the Middlesex-London Health Unit coverage area — a rate of 1,813 per 100,000 people — a new study by the Ontario Drug Policy Research Network says.
Federal Health Minister Ginette Petitpas Taylor was at St. Michael’s Hospital on Wednesday morning to announce $10.7 million in funding to support a number of new initiatives focused on addressing Canada’s opioid crisis.
Study shows opioid guidelines unintentionally cause experiences of stigma and loss of autonomy amongst those who take opioids
Published in the International Journal of Drug Policy, a study conducted by the Ontario Drug Policy Research Network (ODPRN) of St. Michael’s Hospital found that the introduction of opioid-related policies had unintended consequences for people who take opioids.
A new study has found that women who began methadone maintenance therapy (MMT) during later stages of pregnancy did not have increased risks of many perinatal adverse health outcomes compared to pregnant women who initiated the treatment for opioid use disorder earlier.
Prescriptions for stimulants such as Ritalin, Adderall rising in Ontario, particularly for teen boys: report
Use of prescription stimulants has risen nearly 30 per cent in the past five years, a new study says, but girls are less likely to be taking the drugs than boys, meaning some cases of attention-deficit hyperactivity disorder may be going undiagnosed.
A new multimedia project, titled the Opioid Chapters, delves beyond the data to share the personal experiences of those affected by the crisis.
About a third of deaths caused by opioids in Ontario in 2016 were among people who had been prescribed the drugs, a study published Wednesday shows.
Treatment with pregabalin (Lyrica), an anticonvulsant also approved for several forms of chronic pain, was associated with an increased risk for opioid-related death when co-prescribed with opioids, Canadian researchers reported.
Scientists at the Ontario Drug Policy Research Network have unveiled an interactive tool that shows opioid prescription rates across the province, enabling users to quickly evaluate the impact of programs designed to deal with the opioid crisis.
People who are prescribed a combination pill to manage their high blood pressure are more likely to take their medicine as instructed and have better health outcomes than those who take the same medications prescribed as separate pills, according to a new study published today.
In 2016, one in 65 deaths in the United States involved opioids — and among younger adults, that number skyrocketed to one in five, according to a new study.
Researchers say 23.9 per cent of initial opioid prescriptions in Ontario during that time had a daily dose of more than 50 milligram morphine equivalents.
A new study finds a steep rise in opioid-related deaths in Ontario among teens and young adults. Researchers at St. Michael’s Hospital in Toronto say one out of six deaths among Ontarians aged 25 to 34 was related to opioids in 2015.
There are almost 130,000 Ontario residents who have “catastrophic” drug expenses and need government assistance to cover their costly medications, a new study shows.
A new study from Mount Sinai hospital suggests that emergency departments may be helping to fuel Canada’s opiate crisis.